What happens to originator medicines when (generic) followers enter the public market

Claudia Habl (Gesundheit Österreich GmbH, GÖG), Christine Leopold (Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, USA)

The poster was presented at the 19th ISPOR Annual European Congress, 29 Oct -2 Nov 2016, Vienna.

Read more